• Star Catcher

  Participated · Series A · May 2026

  Star Catcher is developing an orbital optical power-beaming energy infrastructure designed to transmit concentrated, conditioned solar energy to client satellites, enabling up to 10x more power without receiver retrofits. The company has demonstrated world-record optical power beaming performance and completed a critical on-orbit subsystem demonstration, validating its end-to-end system architecture. Star Catcher has signed seven power purchase agreements, secured multiple government contracts, and manages a qualified commercial pipeline representing more than $3 billion in projected annual recurring revenue. It plans to launch the first space-based optical power beaming demonstration later this year and is already advancing a second mission to retire technical risk and deploy operational capability. Financially, Star Catcher has raised $88 million to date, including a $65 million Series A intended to scale engineering, operations, commercial expansion, and national security engagement.

• Kibu

  Participated · Seed · Apr 2026

  Kibu provides an app-based human network that cryptographically binds real human identity to verified interactions using biometric-protected devices, liveness testing, and cryptographic proof. Users build non-discoverable, confirmed Connections that enable secure communication, authorization, and group decisions where identity must be established beforehand. The platform is in use across financial services, security consulting, family offices, and government agencies. Kibu emphasizes establishing trust before communication occurs to address AI-driven impersonation, deepfakes, and account compromise. The company was founded by experts in cybersecurity policy and privacy stewardship and is backed by investors including Cubit Capital, Construct Capital, Slow Ventures, Helena, and Silver Buckshot Ventures. With the recent seed, Kibu has $14 million in total funding and plans to scale adoption and expand its infrastructure to integrate its trust fabric into other tools and workflows.

• Positron

  Participated · Series B · Feb 2026

  Founded in 2023 and based in Reno, Nevada, Positron develops energy-efficient AI inference hardware, including its shipped Atlas inference system. Atlas has already been delivered to customers such as Cloudflare, and the company claims its hardware can deliver more than 3.5x performance per watt versus Nvidia's latest products on certain inference workloads. Positron is developing a next-generation chip called Asimov, targeting tape-out in late 2026 and production in early 2027. The company emphasizes U.S. manufacturing and energy efficiency as core differentiators. Positron has raised roughly $309 million to date, including a $230 million Series B in February 2026 that valued the company above $1 billion. CEO Mitesh Agrawal has led the company since before its seed round.

• Phaidra

  Participated · Series B · Oct 2025

  Phaidra develops intelligent control systems that use reinforcement learning to orchestrate power, cooling, and workload management across AI factories—data centers purpose-built for AI workloads. By coordinating these historically separate systems, the company unlocks efficiency gains that reduce costs and environmental impact. Current products include AI agents for liquid cooling, chiller plants, and workload scheduling, all designed to operate beyond the limits of traditional controls logic or human intuition. Phaidra already collaborates closely with NVIDIA to design next-generation AI infrastructure and plans to deepen this partnership. Proceeds from its latest financing will accelerate agent ecosystem development and support expansion to additional global operators. The company was founded by Jim Gao, Vedavyas Panneershelvam, and Katherine Hoffman, who collectively bring experience from Google DeepMind, AlphaGo, Trane, and Raytheon. Headquartered in Seattle, Phaidra positions itself at the intersection of profitability and sustainability in an energy-constrained world. Its recent Series B raise of more than $50 million underscores investor confidence in its mission.

• Lykos Therapeutics

  Led · Series A · Jan 2024

  Lykos Therapeutics (formerly MAPS Public Benefit Corporation) develops investigational MDMA-assisted therapy to treat post-traumatic stress disorder (PTSD). The company has completed two randomized, double-blind, placebo-controlled Phase 3 trials (MAPP1 and MAPP2) that met primary and secondary endpoints and has submitted a new drug application (NDA) to the U.S. Food and Drug Administration. If approved, the therapy would be the first psychedelic-assisted therapy for PTSD; Lykos is preparing regulatory and pre-launch activities to integrate the therapy into the healthcare system. Lykos rebranded from MAPS PBC and is transitioning from a research-stage organization to a for-profit public benefit corporation focused on commercialization; it was founded by the non-profit MAPS in 2014. The company notes Breakthrough Therapy designation for MDMA since 2017 and has requested Priority Review of its NDA, while also stating that MDMA-assisted therapy has not been approved and its safety and efficacy have not been established. The recent financing will support regulatory, pre-launch and commercialization preparations.

No current team members are available.